Table 1. Correlation between clinicopathological features and CDK5 expression levels.
| Variables | n |
CDK5 expression |
χ2 a | P | |
|---|---|---|---|---|---|
| Low | High | ||||
| Gender | 0.32 | 0.572 | |||
| Male | 46 | 22 | 24 | ||
| Female | 43 | 18 | 25 | ||
| Age (years) | 0.103 | 0.748 | |||
| <59 | 26 | 11 | 15 | ||
| ⩾59 | 63 | 29 | 34 | ||
| Tumor size (cm in diameter) | 10.156 | 0.001 | |||
| <5 | 37 | 24 | 13 | ||
| ⩾5 | 52 | 16 | 36 | ||
| Nodal metastasis | 4.867 | 0.027 | |||
| N0 | 58 | 31 | 27 | ||
| N1/2 | 31 | 9 | 22 | ||
| Differentiation | 6.619 | 0.034 | |||
| Well | 21 | 14 | 7 | ||
| Moderate | 55 | 23 | 32 | ||
| Poor | 13 | 3 | 10 | ||
| AJCC stage | 6.619 | 0.01 | |||
| I/II | 56 | 31 | 25 | ||
| III/IV | 33 | 9 | 24 | ||
Pearson's chi-square was used for the assay. Significant at P<0.05